Timing of maternal-infant HIV transmission associations between intrapartum factors and early polymerase chain reaction results

AIDS

Volumn 11, Issue 4, 1997, Pages 429-435

  Kuhn, Louise ^a   Abrams, Elaine J ^b   Matheson, Pamela B ^c   Thomas, Pauline A ^d   Lambert, Genevieve ^e   Bamji, Mahrukh ^f   Greenberg, Barbara ^g   Steketee, Richard W ^h   Thea, Donald M ^c  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b HARLEM HOSPITAL CENTER   (United States)

^c Med Hlth Res Assoc New York C   (United States)

^d NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^e BRONX LEBANON HOSPITAL CENTER   (United States)

^f METROPOLITAN HOSPITAL CENTER   (United States)

^g MONTEFIORE MEDICAL CENTER   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Intrauterine growth retardation; Maternal infant HIV transmission; Mode of delivery; Polymerase chain reaction; Preterm delivery; Rupture of membranes; Timing

Indexed keywords

VIRUS DNA;

ARTICLE; CESAREAN SECTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAUTERINE INFECTION; MAJOR CLINICAL STUDY; NEWBORN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SMALL FOR DATE INFANT; UNITED STATES; VAGINAL DELIVERY; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 0031041229     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199704000-00005     Document Type: Article

References (25)

1. Bryson YJ, Luzuriaga K, Sullivan JL, Wara DW: Proposed definitions for in utero versus intrapartum transmission of HIV-1 [letter]. N Engl J Med 1992, 327:1246-1247
2. Rogers MF, Ou CY, Rayfield M, et al.: Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. N Engl J Med 1989, 320:1649-1654
3. Burgard M, Mayaux MJ, Blanche S, et al.: The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates. N Engl J Med 1992, 327:1192-1197.
4. Krivine A, Firtion G, Cao L, Francoual C, Henrion R, Lebon P: HIV replication during the first weeks of life. Lancet 1992, 339:1187-1189.
5. Comeau AM, Hsu HW, Schwerzler M, et al.: Identifying human immunodeficiency virus infection at birth: application of polymerase chain reaction to Guthrie cards. J Pediatr 1993, 123:252-258.
6. Dunn DT, Brandt CD, Krivine A, et al.: The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. AIDS 1995, 9:F7-F11.
7. Minkoff H, Burns DN, Landesman S, et al.: The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus. Am J Obstet Gynecol 1995, 173:585-589.
8. Goedert JJ, Duliegs AM, Amos CI, Felton S, Biggar RJ: High risk of HIV-1 infection for first-born twins. Lancet 1991, 338:1471-1475.
9. Duliegt AM, Amos CI, Felton S, Biggar RJ, Goedert JJ: Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins. J Pediatr 1995, 126:625-632.
10. European Collaborative Study: Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet 1994, 343:1464-1467.
11. European Collaborative Study: Risk factors for mother-to-child transmission of HIV-1. Lancet 1992, 339:1007-1012.
12. Boyer PJ, Dillon M, Navaie M, et al.: Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA 1994, 271:1925-1930.
13. Burns DN, Landesman S, Muenz LR et al.: Cigarette smoking, premature rupture of membranes, and vertical transmission of HIV-1 among women with low CD4+ levels. J Acquir Immune Defic Syndr 1994, 7:718-726.
14. Kuhn L, Stein ZA, Thomas PA, Singh T, Isai WY: Maternal-infant HIV transmission and circumstances of delivery. Am J Public Health 1994, 84:1110-1115.
15. Mofenson LM: A critical review of studies evaluating the relationship of mode of delivery to perinatal transmission of human immunodeficiency virus. Pediatr Infect Dis J 1995, 14:169-176.
16. Abrams EJ, Matheson PB, Thomas PA, et al.: Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. Pediatrics 1995, 96:451-458.
17. Thomas PA, Weedon J, Krasinski K, et al.: Maternal predictors of perinatal human immunodeficiency virus transmission. Pediatr Infact Dis J 1994, 13:489-495.
18. Matheson PB, Weedon J, Cappelli M, et al.: Comparison of methods of estimating the mother-to-child transmission rate of human immunodeficiency virus type 1 (HIV-1). Am J Epidemiol 1995, 142:714-718.
19. Landesman SH, Kalish LA, Burns DN, et al.: Obstetrical factors ar.d the transmission of human immunodeficiency virus type 1 from mother to child. N Engl J Med 1996, 334:1617-1623.
20. Viscarello RR, Copperman AB, DeGennaro NJ: Is the risk of perinatal transmission of human immunodeficiency virus increased by the intrapartum use of spiral electrodes or fetal scalp pH sampling? Am J Obstet Gynecol 1994, 170:740-743.
21. Kuhn L, Abrams EJ, Chinchilla M, Tsai WY, Thea DM: Sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period [letter]. AIDS 1996, 10:1181-1182.
22. Goedert JJ, Mendez H, Drummond JE, et al.: Mother-to-infant transmission of human immunodeficiency virus type 1 : association with prematurity or low anti-gp120. Lancet 1989, ii:1351-1354.
23. Rouzioux C, Costagliola D, Burgard M, et al.: Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a markov model. Am J Epidemiol 1995, 142:1330-1337.
24. Matheson PB, Abrams EJ, Thomas PA, et al.: Efficacy of antenatal zidovudine in reducing perinatal transmission of human immunodeficiency virus type 1. J Infect Dis 1995, 172:353-358.
25. Rouzioux C, Costagliola D, Burgard M, et al.: Timing of mother-to-child HIV-1 transmission depends on maternal status. AIDS 1993, 7 (suppl 2):S49-S52.